{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:50:43Z","timestamp":1790250643674,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.intimp.2005.11.015","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T18:00:20Z","timestamp":1134669620000},"page":"535-542","source":"Crossref","is-referenced-by-count":139,"title":["Adverse events associated with intravenous immunoglobulin therapy"],"prefix":"10.1016","volume":"6","author":[{"given":"David J.","family":"Hamrock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2005.11.015_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-112-4-278","article-title":"Clinical use of intravenous immunoglobulin","volume":"112","author":"Berkman","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib3","series-title":"Textbook of Pediatrics","first-page":"567","article-title":"Primary B-cell diseases","author":"Buckley","year":"1996"},{"key":"10.1016\/j.intimp.2005.11.015_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-121-4-199408150-00004","article-title":"Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors","volume":"121","author":"Sekul","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib5","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1537-2995.2003.00519.x","article-title":"Intravenous immune globulins: an update for clinicians","volume":"43","author":"Knezevic-Maramica","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.intimp.2005.11.015_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.47.3.674","article-title":"Complications of intravenous immune globulin treatment in neurologic disease","volume":"47","author":"Brannagan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2005.11.015_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00002826-199710000-00002","article-title":"Side effects of high-dose intravenous immunoglobulins","volume":"20","author":"Stangel","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.intimp.2005.11.015_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0887-7963(03)00038-5","article-title":"Risks associated with the use of intravenous immunoglobulin","volume":"17","author":"Pierce","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.intimp.2005.11.015_bib9","series-title":"Cecil Essentials of Medicine","first-page":"641","article-title":"Infections of the nervous system","author":"Carpenter","year":"1993"},{"key":"10.1016\/j.intimp.2005.11.015_bib10","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1001\/jama.1988.03720220017011","article-title":"Administration of immune globulin associated with aseptic meningitis","volume":"259","author":"Kato","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2005.11.015_bib11","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/BF01959803","article-title":"Aseptic meningitis: a frequent side effect of intravenous immunoglobulin?","volume":"154","author":"Preminger-Shapiro","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.intimp.2005.11.015_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM199008303230917","article-title":"Intravenous immune globulin and acute aseptic meningitis","volume":"323","author":"Casteels-Van Daele","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib13","first-page":"117","article-title":"Aseptic meningitis syndrome (AMS) after IV gammaglobulin (I.V. Gg) therapy for ITP","volume":"12","author":"Jayabose","year":"1990","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.intimp.2005.11.015_bib14","first-page":"539","article-title":"Intravenous immune globulin and aseptic meningitis","volume":"146","author":"Rao","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.intimp.2005.11.015_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00006565-200212000-00006","article-title":"Aseptic meningitis due to administration of intravenous immunoglobulin with an unusually high number of leukocytes in cerebrospinal fluid","volume":"18","author":"Obando","year":"2002","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.intimp.2005.11.015_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-3476(97)70355-X","article-title":"Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G","volume":"130","author":"Kattamis","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.intimp.2005.11.015_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00043426-199208000-00019","article-title":"Acute aseptic meningitis associated with administration of intravenous immune globulin","volume":"14","author":"Pallares","year":"1992","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.intimp.2005.11.015_bib18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/00006454-199210000-00020","article-title":"Cerebrospinal fluid inflammation induced by intravenous immunoglobulins","volume":"11","author":"Kressebuch","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.intimp.2005.11.015_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01701743","article-title":"Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura","volume":"67","author":"Mitterer","year":"1993","journal-title":"Ann Hematol"},{"key":"10.1016\/j.intimp.2005.11.015_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/jnnp.56.7.830-a","article-title":"Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis","volume":"56","author":"Meiner","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.intimp.2005.11.015_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/mus.880170620","article-title":"Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis","volume":"17","author":"Ellis","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.intimp.2005.11.015_bib22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/clinids\/18.6.1008","article-title":"Aseptic granulocytic meningitis following treatment with intravenous immunoglobulin","volume":"18","author":"De Vlieghere","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.intimp.2005.11.015_bib23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/106002809603001010","article-title":"Meningitis and hepatitis complicating intravenous immunoglobulin therapy","volume":"30","author":"Shorr","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.intimp.2005.11.015_bib24","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/bmj.315.7117.1203","article-title":"Aseptic meningitis associated with high-dose immunoglobulin: case report","volume":"315","author":"Picton","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2005.11.015_bib25","first-page":"2491","article-title":"Aseptic meningitis as a side effect of intravenous immune gammaglobulin","volume":"24","author":"Lafferty","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.intimp.2005.11.015_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/clind\/15.3.564","article-title":"Aseptic meningitis following administration of intravenous immune globulin","volume":"15","author":"Molina","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.intimp.2005.11.015_bib27","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1212\/WNL.44.6.1180","article-title":"Cerebral infarction following intravenous immunoglobulin therapy for myasthenia gravis","volume":"44","author":"Steg","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2005.11.015_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jnnp.54.3.275","article-title":"Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy","volume":"54","author":"Watson","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.intimp.2005.11.015_bib29","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.42.8.1636-a","article-title":"Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"42","author":"Vera-Ramirez","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2005.11.015_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/ajkd.2002.35899","article-title":"Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin","volume":"40","author":"Tsinalis","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.intimp.2005.11.015_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1096-8652(200102)66:2<151::AID-AJH1035>3.0.CO;2-Q","article-title":"Intravenous gammaglobulin-associated acute renal failure","volume":"66","author":"Gupta","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.intimp.2005.11.015_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2001.02742.x","article-title":"Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy","volume":"113","author":"Sati","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.intimp.2005.11.015_bib33","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1345\/aph.18305","article-title":"Acute renal failure after large doses of intravenous immune globulin","volume":"33","author":"Haskin","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.intimp.2005.11.015_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1046\/j.1365-2141.1998.00778.x","article-title":"Intravenous immunoglobulin therapy and renal dysfunction","volume":"101","author":"Windrum","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.intimp.2005.11.015_bib35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9343(87)90110-0","article-title":"Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin","volume":"82","author":"Barton","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/jnnp.71.4.562","article-title":"Call for guidelines for monitoring renal function and haematological variables during intravenous infusion of immunoglobulin in neurological patients","volume":"71","author":"Bajaj","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.intimp.2005.11.015_bib37","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/ndt\/13.9.2364","article-title":"Prolonged acute renal failure after I.V. immunoglobulin therapy in the refeeding phase of anorexia nervosa","volume":"13","author":"Stahl","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.intimp.2005.11.015_bib38","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.V8111788","article-title":"Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature","volume":"8","author":"Cayco","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2005.11.015_bib39","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ndt\/12.7.1497","article-title":"Acute renal failure associated with immunoglobulin administration","volume":"12","author":"Michail","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.intimp.2005.11.015_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/j.1875-9114.1995.tb02894.x","article-title":"Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report","volume":"15","author":"Winward","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.intimp.2005.11.015_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000190187","article-title":"Paradoxical and persistent renal impairment in Henoch\u2013Sch\u00f6nlein purpura after high-dose immunoglobulin therapy","volume":"76","author":"Blanco","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.intimp.2005.11.015_bib42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF01701493","article-title":"High-dose intravenous IgG treatment and acute renal failure","volume":"21","author":"Veber","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0272-6386(95)90003-9","article-title":"Acute renal failure associated with immunoglobulin therapy","volume":"25","author":"Cantu","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.intimp.2005.11.015_bib44","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archinte.154.17.1985","article-title":"Intravenous immunoglobulin-induced osmotic nephrosis","volume":"154","author":"Ahsan","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib45","first-page":"347","article-title":"Acute renal failure after intravenous immunoglobulin therapy","volume":"21","author":"Pasatiempo","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.intimp.2005.11.015_bib46","first-page":"338","article-title":"Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura","volume":"78","author":"Ruggeri","year":"1993","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2005.11.015_bib47","first-page":"217","article-title":"Renal failure and intravenous immunoglobulin","volume":"37","author":"Phillips","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.intimp.2005.11.015_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archneur.1993.00540020015010","article-title":"Acute renal failure resulting from intravenous immunoglobulin therapy","volume":"50","author":"Tan","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1016\/j.intimp.2005.11.015_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1423-0410.1993.tb02159.x","article-title":"Renal toxicity of intravenous immunoglobulin","volume":"65","author":"Stewart","year":"1993","journal-title":"Vox Sang"},{"key":"10.1016\/j.intimp.2005.11.015_bib50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/qjmed\/93.11.751","article-title":"Nephrotoxicity of intravenous immunoglobulin","volume":"93","author":"Levy","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.intimp.2005.11.015_bib51","first-page":"216","article-title":"Renal toxicity of intravenous immunoglobulin","volume":"37","author":"Kobosko","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.intimp.2005.11.015_bib52","first-page":"295","article-title":"Use of high-dose intravenous immunoglobulin in systemic lupus erythematosus: report of three cases","volume":"7","author":"Corvetta","year":"1989","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.intimp.2005.11.015_bib53","first-page":"83","article-title":"Pulmonary and renal toxicity of intravenous immunoglobulin","volume":"36","author":"Rault","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.intimp.2005.11.015_bib54","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJM199210013271416","article-title":"High-dose intravenous immune globulin and acute renal failure","volume":"327","author":"Ellie","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0140-6736(91)93395-P","article-title":"High-dose intravenous IgG treatment and renal function","volume":"337","author":"Schifferli","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2005.11.015_bib56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0140-6736(91)90043-O","article-title":"Intravenous IgG for glomerulonephritis and renal function","volume":"338","author":"Rostoker","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2005.11.015_bib57","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0272-6386(96)90505-3","article-title":"Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis","volume":"28","author":"Hansen-Schmidt","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.intimp.2005.11.015_bib58","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/ndt\/14.3.795b","article-title":"Henoch\u2013Sch\u00f6nlein nephritis. Adverse effect of treatment with intravenous immunoglobulin","volume":"14","author":"Villarreal","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.intimp.2005.11.015_bib59","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000169055","article-title":"Acute renal failure following immunoglobulin therapy","volume":"16","author":"Ahsan","year":"1996","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.intimp.2005.11.015_bib60","first-page":"862","article-title":"Acute renal failure induced by intravenous immune globulin","volume":"53","author":"Arunabh","year":"1996","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.intimp.2005.11.015_bib61","first-page":"483","article-title":"Transient renal failure in a patient with idiopathic thrombocytopenia purpura after treatment with concomitant protein-a immunosorption and IVIG","volume":"80","author":"Friedman","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2005.11.015_bib62","first-page":"901","article-title":"Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy","volume":"93","author":"Zhang","year":"2000","journal-title":"South Med J"},{"key":"10.1016\/j.intimp.2005.11.015_bib63","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000326232","article-title":"Macrophagelike vacuolated renal tubular cells in the urine of a male with osmotic nephrosis associated with intravenous immunoglobulin therapy. A case report","volume":"44","author":"Khalil","year":"2000","journal-title":"Acta Cytol"},{"key":"10.1016\/j.intimp.2005.11.015_bib64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2516.1999.00327.x","article-title":"Acute renal failure in acquired haemophilia following the use of high-dose intravenous immunoglobulin","volume":"5","author":"Laidlaw","year":"1999","journal-title":"Haemophilia"},{"key":"10.1016\/j.intimp.2005.11.015_bib65","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1365-2516.1999.00292.x","article-title":"Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia","volume":"5","author":"McColl","year":"1999","journal-title":"Haemophilia"},{"key":"10.1016\/j.intimp.2005.11.015_bib66","first-page":"60","article-title":"Important drug warning: acute renal failure associated with immune globulin intravenous (human)","volume":"19","author":"Epstein","year":"2000","journal-title":"Neonatal Netw"},{"key":"10.1016\/j.intimp.2005.11.015_bib67","first-page":"1983","article-title":"Renal lesions following administration of hypertonic solutions of sucrose","volume":"114","author":"Anderson","year":"1940","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2005.11.015_bib68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000179925","article-title":"Pinocytosis as cause of sucrose nephrosis","volume":"8","author":"Schwartz","year":"1971","journal-title":"Nephron"},{"key":"10.1016\/j.intimp.2005.11.015_bib69","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/01.WNL.0000068335.01620.9D","article-title":"The clinical features of 16 cases of stroke associated with administration of IGIV","volume":"60","author":"Caress","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2005.11.015_bib70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1468-1331.2003.00542.x","article-title":"Thrombosis complicating high-dose intravenous immunoglobulin: report of three cases and review of the literature","volume":"10","author":"Zaidan","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.intimp.2005.11.015_bib71","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1212\/WNL.59.3.458","article-title":"Neuropathologic findings in a Guillain\u2013Barr\u00e9 patient with strokes after IGIV therapy","volume":"59","author":"Byrne","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2005.11.015_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/ard.59.1.77","article-title":"Acute myocardial infarction associated with high-dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases","volume":"59","author":"Elkayam","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2005.11.015_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(86)92511-0","article-title":"Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients","volume":"2","author":"Woodruff","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2005.11.015_bib74","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.42.1.257","article-title":"Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis","volume":"42","author":"Silbert","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2005.11.015_bib75","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N","article-title":"Complications of intravenous gammaglobulin in neuromuscular and other diseases","volume":"19","author":"Bertorini","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.intimp.2005.11.015_bib76","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archderm.139.8.991","article-title":"Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions","volume":"139","author":"Katz","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.015_bib77","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1067\/mjd.2002.122735","article-title":"Treatment of pemphigus with intravenous immunoglobulin","volume":"47","author":"Bystryn","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.015_bib78","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1592\/phco.22.17.1638.34125","article-title":"Thrombotic complications after intravenous immunoglobulin therapy in two patients","volume":"22","author":"Emerson","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.intimp.2005.11.015_bib79","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/jnnp.68.6.790","article-title":"Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome","volume":"68","author":"Turner","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.intimp.2005.11.015_bib80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.44.2.223","article-title":"High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events","volume":"44","author":"Dalakas","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2005.11.015_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/000331970205300117","article-title":"Intravenous immunoglobulin-related acute coronary syndrome and coronary angiography in idiopathic thrombocytopenic purpura\u2014a case report and literature review","volume":"53","author":"Crouch","year":"2002","journal-title":"Angiology"},{"key":"10.1016\/j.intimp.2005.11.015_bib82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1096-8652(200010)65:2<177::AID-AJH17>3.0.CO;2-K","article-title":"Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP)","volume":"65","author":"Paolini","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.intimp.2005.11.015_bib83","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(86)92182-3","article-title":"Thrombotic events after intravenous immunoglobulin","volume":"2","author":"Frame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2005.11.015_bib84","first-page":"775","article-title":"Intravenous immunoglobulin, blood viscosity, and myocardial infarction","volume":"13","author":"Fisman","year":"1997","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.intimp.2005.11.015_bib85","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/art.38","article-title":"Myocardial infarction as a complication of immunoglobulin therapy","volume":"40","author":"Rosenbaum","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2005.11.015_bib86","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.57.9.1699","article-title":"Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders","volume":"57","author":"Grillo","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2005.11.015_bib87","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneur.1992.00530330103025","article-title":"Early Guillain\u2013Barr\u00e9 syndrome without inflammation","volume":"49","author":"Ropper","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.intimp.2005.11.015_bib88","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","article-title":"Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases","volume":"139","author":"Prins","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.015_bib89","first-page":"115","article-title":"Intravenous immune globulin (IVIG) precipitating acute myocardial infarction","volume":"43","author":"Struble","year":"2002","journal-title":"J Miss State Med Assoc"},{"key":"10.1016\/j.intimp.2005.11.015_bib90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000075091","article-title":"Acute myocardial infarction following intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy in association with a monoclonal immunoglobulin G paraprotein","volume":"51","author":"Stamboulis","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.intimp.2005.11.015_bib91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4065\/75.1.83","article-title":"Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications","volume":"75","author":"Go","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.intimp.2005.11.015_bib92","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/014107680109400412","article-title":"Pulmonary embolism after intravenous immunoglobulin","volume":"94","author":"Alliot","year":"2001","journal-title":"J R Soc Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib93","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0002-9394(14)70844-X","article-title":"Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration","volume":"124","author":"Oh","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.intimp.2005.11.015_bib94","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM198602273140907","article-title":"Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA","volume":"314","author":"Burks","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2005.11.015_bib95","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/0140-6736(90)92374-Q","article-title":"Anaphylaxis with intravenous gammaglobulin","volume":"336","author":"McCluskey","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2005.11.015_bib96","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/00365516509077057","article-title":"Studies on the serum gamma-A-globulin level: 3. The frequency of A-gamma-A-globulinemia","volume":"17","author":"Bachmann","year":"1965","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.intimp.2005.11.015_bib97","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-3083.1983.tb00885.x","article-title":"Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA","volume":"18","author":"Hammarstrom","year":"1983","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.intimp.2005.11.015_bib98","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1537-2995.2004.03316.x","article-title":"A new strategy for the prevention of IgA anaphylactic transfusion reactions","volume":"44","author":"Salama","year":"2004","journal-title":"Transfusion"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576905003103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576905003103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T19:40:03Z","timestamp":1706816403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576905003103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1567576905003103"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2005.11.015","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}